Form D · Biotechnology
34 Lives, PBC
West Lafayette, IN · CIK 0002060893
Offering snapshot reported Jul 25, 2025 · SEC filing
- Reported sold
- $0 Indefinite offering
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Jul 15, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 25, 2025 | Initial | $0 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-552751
The offering contemplates the exchange of certain promissory notes for common stock.
Source: Form D, filed Jul 25, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Bauer | Director |
| Marvin Eichorn | Director |
| Chris Jaynes | Director, Executive |
| Kevin Longino | Director |
| Scott Niswonger | Director |
| Kathleen St. Jean | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1281 Win Hentschel Blvd. Ste. 2528
West Lafayette, IN, 47906
West Lafayette, IN, 47906